Matheus Pileggi Camargo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matheus Pileggi Camargo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Ofenhejm Gotfryd
Irmandade da Santa Casa de Misericordia de Sao Paulo, Brazil
1 shared publication - Deusimar Cristian dos Santos Gomez
Santa Casa de Misericórdia de São Paulo, Brazil
1 shared publication - Eduardo Achar Filho
Irmandade da Santa Casa de Misericordia de Sao Paulo, Brazil
1 shared publication - Fernando Balsimelli
Faculdade de Ciencias Médicas da Santa Casa de São Paulo, Brazil
1 shared publication - Gabriel Daris Ribeiro
Faculdade de Ciencias Médicas da Santa Casa de São Paulo, Brazil
1 shared publication - João Tomás Fernandes Castilho Garcia
Irmandade da Santa Casa de Misericordia de Sao Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Coluna/Columna
- Vol. 25 (3)
ANALYSIS OF A PREEMPTIVE ANTIBIOTIC THERAPY PROTOCOL IN INSTRUMENTED SPINAL ARTHRODESIS
Objective: To describe the clinical profile and postoperative outcomes of patients undergoing instrumented spinal arthrodesis under a preemptive antibiotic therapy protocol with vancomycin and ciprofloxacin. Methods: A retrospective, consecutive, and single-center case series was conducted involving 88 patients operated on between January 2021 and December 2022. The protocol consisted of intravenous vancomycin (1 g) and ciprofloxacin (400 mg) administered 60 minutes before incision, with postoperative maintenance for five days. The minimum clinical follow-up was 24 months. Results: The mean age was 45.2 years, with a male predominance (60.2%). Trauma was the most frequent surgical indication (38.9%), followed by neoplasms (25%). The overall arthrodesis infection rate was 4.5% (4/88 patients), with 75% of these cases occurring in patients with oncological etiology. Only one adverse event (1.1%) related to vancomycin was recorded. Conclusions: The preemptive antibiotic therapy protocol showed favorable infection rates (4.5%) and good pharmacological tolerability in the studied sample, suggesting it is a viable strategy for high-complexity spine surgeries. Level of Evidence IV; Case series.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Coluna/Columna
- Vol. 25 (3)
Open AccessANALYSIS OF A PREEMPTIVE ANTIBIOTIC THERAPY PROTOCOL IN INSTRUMENTED SPINAL ARTHRODESIS
Objective: To describe the clinical profile and postoperative outcomes of patients undergoing instrumented spinal arthrodesis under a preemptive antibiotic therapy protocol with vancomycin and ciprofloxacin. Methods: A retrospective, consecutive, and single-center case series was conducted involving 88 patients operated on between January 2021 and December 2022. The protocol consisted of intravenous vancomycin (1 g) and ciprofloxacin (400 mg) administered 60 minutes before incision, with postoperative maintenance for five days. The minimum clinical follow-up was 24 months. Results: The mean age was 45.2 years, with a male predominance (60.2%). Trauma was the most frequent surgical indication (38.9%), followed by neoplasms (25%). The overall arthrodesis infection rate was 4.5% (4/88 patients), with 75% of these cases occurring in patients with oncological etiology. Only one adverse event (1.1%) related to vancomycin was recorded. Conclusions: The preemptive antibiotic therapy protocol showed favorable infection rates (4.5%) and good pharmacological tolerability in the studied sample, suggesting it is a viable strategy for high-complexity spine surgeries. Level of Evidence IV; Case series.